284
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

A Fermented Substance from Aspergillus phoenicis Reduces Liver Fibrosis Induced by Carbon Tetrachloride in Rats

, , &
Pages 1154-1161 | Received 26 Oct 2006, Accepted 02 Feb 2007, Published online: 22 May 2014

  • 1) Poli, G., Pathogenesis of liver fibrosis: role of oxidative stress. Mol. Aspects Med., 21, 49–98 (2000).
  • 2) Lengyel, G., and Tulassay, Z., Antioxidant therapy in chronic liver disease. Orv. Hetil., 147, 1113–1118 (2006).
  • 3) Miyake, Y., Minato, K., Fukumoto, S., Yamamoto, K., Oya-Ito, T., Kawakishi, S., and Osawa, T., New potent antioxidative hydroxyflavanones produced with Aspergillus saitoi from flavanone glycoside in citrus fruit. Biosci. Biotechnol. Biochem., 67, 1443–1500 (2003).
  • 4) Malpure, P. P., Shah, A. S., and Juvekar, A. R., Antioxidant and anti-inflammatory activity of extract obtained from Aspergillus candidus MTCC 2202 broth filtrate. Indian J. Exp. Biol., 44, 468–473 (2006).
  • 5) Yagi, R., and Doi, M., Isolation of an antioxidative substance produced by Aspergillus repens. Biosci. Biotechnol. Biochem., 63, 932–933 (1999).
  • 6) Marklund, S., and Marklund, G., Involvement of the superoxide anion radical in the autooxidation of pyrogallol and convenient assay for superoxide dismutase. Eur. J. Biochem., 47, 469–474 (1975).
  • 7) Ohkawa, H., Ohishi, N., and Yagi, K., Assay for lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal. Biochem., 95, 351–358 (1979).
  • 8) Lowry, O. H., Rosebrough, N. J., Farm, A. L., and Randall, R. J., Protein measurement with the Folino phenol reagent. J. Biol. Chem., 193, 265–275 (1951).
  • 9) Neuman, R. E., and Logan, M. A., The determination of hydroxyproline. J. Biol. Chem., 184, 299–306 (1950).
  • 10) Chomczynski, P., and Sacchi, N., Single-step method of RNA isolation by acid guanidium thiocyanate–phenol–chloroform extraction. Anal. Biochem., 162, 156–159 (1987).
  • 11) Primer3. Code available at http://www.genome.wi.mit.edu/genome-software/other/primer3,html.
  • 12) Ruwart, M. J., Wilkinson, K. E., Rush, B. D., Vidmar, T. J., Peters, K. M., and Henley, K. S., The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology, 10, 801–806 (1989).
  • 13) Sturgill, M. G., and Lambert, G. H., Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin. Chem., 43, 1512–1526 (1997).
  • 14) Mato, J. M., Corrales, F. J., Lu, S. C., and Avila, M. A., S-adenosylmethionine: a control switch that regulates liver function. FASEB, 16, 15–26 (2002).
  • 15) Mato, J. M., Alvarez, L., Ortiz, P., and Pajares, M. A., S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol. Ther., 73, 265–280 (1997).
  • 16) Paneda, C., Gorospe, I., Herrera, B., Nakamura, T., Fabregat, I., and Varela-Nieto, I., Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulation. Hepatology, 35, 1381–1391 (2002).
  • 17) Lin, W. C., and Lin, W. L., Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats. World J. Gastroenterol., 12, 265–270 (2006).
  • 18) Podolsky, D. K., and Isselbacher, K. J., Derangements of hepatic metabolism. In “Harrison’s Principles of Internal Medicine,” eds. Wilson, J. D., Braunwald, E., Isselbacher, K. J., Petersdorf, R. G., Martin, J. B., Fauci, A. S., and Root, R. K., McGraw-Hill, New York, pp. 1311–1317 (1998).
  • 19) Gill, M. A., and Kircbain, W. R., Alcoholic liver disease. In “Pharmacotherapy: A Pathophysiologic Approach,” eds. Dipiro, J. T., Talbert, R. L., Yee, G. C., Matzke, G. R., Wells, B. G., and Poser, L. M., A ppleton and Lange, Stamford, pp. 785–800 (1997).
  • 20) Yamada, Y., and Fausto, N., Deficient liver regeneration after carbon tetrachloride in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am. J. Pathol., 152, 1577–1589 (1998).
  • 21) Perez Tamayo, R., Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhosis? Hepatology, 3, 112–120 (1983).
  • 22) Bissel, D. M., Friedman, S. L., Maher, J. J., and Roll, F. J., Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology, 11, 488–498 (1990).
  • 23) Hanauske-Abel, H. M., Fibrosis: representive molecular elements, a basic concept and emerging targets for suppressive treatment. In “Hepatology: A Textbook of Liver Disease,” eds. Zakim, D., and Boyer, T. D., W. B. Saunders, Philadelphia, pp. 465–506 (1996).
  • 24) Lin, W. C., Kuo, S. C., Lin, W. L., Fang, H. L., and Wang, B. C., Filtrate of fermented mycelia from Antrodia camphorate reduces liver fibrosis induced by carbon tetrachloride in rats. World J. Gastroenterol., 12, 2369–2374 (2006).
  • 25) Pierce, R. A., Glaug, M. R., Grecom, R. S., Mackenzie, J. W., Boyd, C. D., and Deak, S. B., Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rats. J. Biol. Chem., 262, 1652–1658 (1987).
  • 26) Kocher, O., Kennedy, S. P., and Madri, J. A., Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region: functional significance. Am. J. Pathol., 37, 1509–1524 (1990).
  • 27) Bachem, M. G., Meyer, D., Melchior, R., Sell, K. M., and Gressner, A. M., Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast like cells: a potential mechanism of self perpetuation in liver fibrogenesis. J. Clin. Invest., 89, 19–27 (1992).
  • 28) Chen, W. X., Li, Y. M., Yu, C. H., Cai, W. M., Zheng, M., and Chen, F., Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease. World J. Gastroenterol., 8, 379–381 (2002).
  • 29) Bataller, R., and Brenner, D. A., Liver fibrosis. J. Clin. Invest., 115, 209–218 (2005).
  • 30) Yan, S., Chen, G. M., Yu, C. H., Zhu, G. F., Li, Y. M., and Zheng, S. S., Expression pattern of matrix metalloproteinases-13 in a rat model of alcoholic liver fibrosis. Hepatobiliary Pancreat. Dis. Int., 4, 569–572 (2005).
  • 31) Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Ricardi, L., Orlandi, S., Prusanski, M., Morelli, A., and Pellicciari, R., A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J. Pharmacol. Exp. Ther., 314, 584–595 (2005).
  • 32) Wasser, S., Ho, J. M., Ang, H. K., and Tan, C. E., Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats. J. Hepatol., 29, 760–771 (1998).
  • 33) Slater, T. F., and Sawyer, B. C., The stimulatory effects of carbon tetrachloride and other halogeno-alkanes on peroxidative reactions in rat liver fractions in vitro. Biochem. J., 123, 805–814 (1971).
  • 34) Camps, J., Bargallo, T., Gimenez, A., Alie, S., Caballeria, J., Pares, A., Joven, J., Masana, L., and Rodes, J., Relationship between hepatic lipid peroxidation and fibrogenesis in carbon tetrachloride-treated rats. Clin. Sci., 83, 695–700 (1992).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.